Impact of neoadjuvant androgen deprivation therapy on postimplant prostate D90 and prostate volume after low‐dose‐rate brachytherapy for localized prostate cancer-Reference-Cited by-同舟云学术

Impact of neoadjuvant androgen deprivation therapy on postimplant prostate D90 and prostate volume after low‐dose‐rate brachytherapy for localized prostate cancer

Published:2021-11-11 Issue:2 Volume:29 Page:143-151
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int J of Urology

Author:

Owari Takuya¹^ORCID,Tanaka Nobumichi¹^ORCID,Nakai Yasushi¹^ORCID,Miyake Makito¹^ORCID,Anai Satoshi¹,Torimoto Kazumasa¹^ORCID,Maesaka Fumisato¹^ORCID,Asakawa Isao²,Yamaki Kaori²,Fuji Tomomi³,Hasegawa Masatoshi²,Fujimoto Kiyohide¹^ORCID

Affiliation:

1. Departments of Urology Nara Medical University Kashihara NaraJapan

2. Department of Radiation Oncology Nara Medical University Kashihara NaraJapan

3. Department of Pathology Nara Medical University Kashihara Nara Japan

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.14738

Reference30 articles.

1. Brachytherapy Improves Biochemical Failure–Free Survival in Low- and Intermediate-Risk Prostate Cancer Compared With Conventionally Fractionated External Beam Radiation Therapy: A Propensity Score Matched Analysis

2. Comparison of Tumor Control and Toxicity Outcomes of High-dose Intensity-modulated Radiotherapy and Brachytherapy for Patients With Favorable Risk Prostate Cancer

3. Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer

4. Comparison of PSA value at last follow-up of patients who underwent low-dose rate brachytherapy and intensity-modulated radiation therapy for prostate cancer

5. American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) Practice Guideline for the Transperineal Permanent Brachytherapy of Prostate Cancer

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Local dose (biologically effective dose ≥180 Gy2) is an important predictor of biochemical recurrence in patients undergoing low‐dose‐rate brachytherapy;International Journal of Urology;2022-09-20

2. Late genitourinary and gastrointestinal toxicity and radiation-induced second primary cancers in patients treated with low-dose-rate brachytherapy;Brachytherapy;2022-09